Initial Clinical Experience with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Signet-Ring Cell Gastric Cancer with Peritoneal Metastases

PURPOSE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been shown to improve survival in select patients with gastric cancer and peritoneal metastases. It remains unclear, however, whether this multimodal treatment protocol is also beneficial for signet-ring...

Descripción completa

Detalles Bibliográficos
Autores principales: Königsrainer, Ingmar, Horvath, Philipp, Struller, Florian, Königsrainer, Alfred, Beckert, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105376/
https://www.ncbi.nlm.nih.gov/pubmed/25061539
http://dx.doi.org/10.5230/jgc.2014.14.2.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105376/
https://www.ncbi.nlm.nih.gov/pubmed/25061539
http://dx.doi.org/10.5230/jgc.2014.14.2.117

Ejemplares similares